Prestige Consumer Healthcare (PBH) Gross Margin Growth (1y) (2011 - 2025)
Prestige Consumer Healthcare (PBH) Gross Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.58 Bn | 86.72 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn | 128.00 |
| 3 | Zoetis | 32.33 Bn | 30.39 Bn | 1.62 Bn | -22.00 |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | -503.00 |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn | -543.00 |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.29 Bn | 18.49 Bn | 1.16 Bn | -271.00 |
| 8 | Neurocrine Biosciences | 17.93 Bn | 16.62 Bn | 800.70 Mn | -9.00 |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn | -8.00 |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.37 Bn | 157.37 Mn | 5.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.00 |
| Sep 30, 2025 | -16.00 |
| Jun 30, 2025 | 158.00 |
| Mar 31, 2025 | 253.00 |
| Dec 31, 2024 | -39.00 |
| Sep 30, 2024 | -43.00 |
| Jun 30, 2024 | -72.00 |
| Mar 31, 2024 | 102.00 |
| Dec 31, 2023 | 127.00 |
| Sep 30, 2023 | 23.00 |
| Jun 30, 2023 | -242.00 |
| Mar 31, 2023 | -198.00 |
| Dec 31, 2022 | -191.00 |
| Sep 30, 2022 | -144.00 |
| Jun 30, 2022 | -128.00 |
| Mar 31, 2022 | -188.00 |
| Dec 31, 2021 | -167.00 |
| Sep 30, 2021 | -89.00 |
| Jun 30, 2021 | 72.00 |
| Mar 31, 2021 | 36.00 |